Surgery Partners, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter, total revenues increased by 17.5% year-over-year to $864.4 million, surpassing Wall Street's revenue expectations.
Full-year 2024 revenue grew 13.5% to $3.1 billion, with Adjusted EBITDA reaching $508.2 million, a 16% increase over 2023. This performance resulted in a 30 basis point margin expansion to 16.3% for the full year. Fourth-quarter same-facility revenues increased by 5.6%.
The company reported a GAAP net loss of $0.86 per share for Q4 2024, but its non-GAAP adjusted profit of $0.44 per share exceeded analysts' consensus estimates by 16.7%. Management also provided full-year 2025 guidance, projecting net revenue between $3.30 billion and $3.45 billion and Adjusted EBITDA between $555 million and $565 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.